Skip to main content
Top
Published in: Aesthetic Plastic Surgery 1/2011

Open Access 01-02-2011 | Review

Enhanced Eyelashes: Prescription and Over-the-Counter Options

Author: Derek Jones

Published in: Aesthetic Plastic Surgery | Issue 1/2011

Login to get access

Abstract

Women have long strived to possess long, thick, and dark eyelashes. Prominent eyes and eyelashes are often considered a sign of beauty and can be associated with increased levels of attractiveness, confidence, and well-being. Numerous options may improve the appearance of eyelashes. Mascara aims to temporarily darken, lengthen, and thicken eyelashes using a combination of waxes, pigments, and resins. Artificial eyelashes can be adhered either to the dermal margin or to individual eyelashes. Individuals may even use eyelash transplantations to improve the appearance of their eyelashes. The unique properties of eyelashes (e.g., relatively long telogen and short anagen phases compared with scalp hairs, slow rate of growth, and a lack of influence by androgens) may allow for specific aesthetic interventions to improve the appearance of natural eyelashes. Some over-the-counter (OTC) products may contain prostaglandin analogs that can affect eyelash growth, but neither the safety nor efficacy of these OTC cosmetics has been fully studied. Originally indicated for the reduction of intraocular pressure, the synthetic prostaglandin analog bimatoprost was recently approved for the treatment of hypotrichosis of the eyelashes. In a double-blinded, randomized, vehicle-controlled trial, bimatoprost safely and effectively grew natural eyelashes, making them longer, thicker, and darker. Bimatoprost was generally safe and well tolerated and appears to provide an additional option for individuals looking to improve the appearance of their eyelashes.
Literature
2.
go back to reference McCurdy JA Jr (2006) Beautiful eyes: characteristics and application to aesthetic surgery. Facial Plast Surg 22:204–214CrossRefPubMed McCurdy JA Jr (2006) Beautiful eyes: characteristics and application to aesthetic surgery. Facial Plast Surg 22:204–214CrossRefPubMed
3.
go back to reference Shaikh MY, Bodla AA (2006) Hypertrichosis of the eyelashes from prostaglandin analog use: a blessing or a bother to the patient? [letter]. J Ocul Pharmacol Ther 22:76–77CrossRefPubMed Shaikh MY, Bodla AA (2006) Hypertrichosis of the eyelashes from prostaglandin analog use: a blessing or a bother to the patient? [letter]. J Ocul Pharmacol Ther 22:76–77CrossRefPubMed
4.
go back to reference DeMello M (2007) Facial hair. In: DeMello M (ed) Encyclopedia of body adornment. Greenwood Publishing Group, Westport, CT, p 109 DeMello M (2007) Facial hair. In: DeMello M (ed) Encyclopedia of body adornment. Greenwood Publishing Group, Westport, CT, p 109
5.
6.
go back to reference Batchelor D (2001) Hair and cancer chemotherapy: consequences and nursing care—a literature study. Eur J Cancer Care (Engl) 10:147–163CrossRef Batchelor D (2001) Hair and cancer chemotherapy: consequences and nursing care—a literature study. Eur J Cancer Care (Engl) 10:147–163CrossRef
10.
go back to reference Randall VA (2007) Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol 18:274–285CrossRefPubMed Randall VA (2007) Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol 18:274–285CrossRefPubMed
11.
go back to reference Moses RA (1970) The eyelids. In: Moses RA (ed) Adler’s physiology of the eye: clinical application, 5th edn. C.V. Mosby, St. Louis, MO, pp 1–16 Moses RA (1970) The eyelids. In: Moses RA (ed) Adler’s physiology of the eye: clinical application, 5th edn. C.V. Mosby, St. Louis, MO, pp 1–16
12.
13.
15.
go back to reference Habif TP (2003) Hair diseases. In: Habif TP (ed) Clinical dermatology: a color guide to diagnosis and treatment, 4th edn. C. V. Mosby, St. Louis, MO Habif TP (2003) Hair diseases. In: Habif TP (ed) Clinical dermatology: a color guide to diagnosis and treatment, 4th edn. C. V. Mosby, St. Louis, MO
16.
go back to reference Elder MJ (1997) Anatomy and physiology of eyelash follicles: relevance to lash ablation procedures. Ophthalmic Plast Reconstr Surg 13:21–25CrossRef Elder MJ (1997) Anatomy and physiology of eyelash follicles: relevance to lash ablation procedures. Ophthalmic Plast Reconstr Surg 13:21–25CrossRef
17.
go back to reference Na JI, Kwon OS, Kim BJ, Park WS, Oh JK, Kim KH, Cho KH, Eun HC (2006) Ethnic characteristics of eyelashes: a comparative analysis in Asian and Caucasian females. Br J Dermatol 155:1170–1176CrossRefPubMed Na JI, Kwon OS, Kim BJ, Park WS, Oh JK, Kim KH, Cho KH, Eun HC (2006) Ethnic characteristics of eyelashes: a comparative analysis in Asian and Caucasian females. Br J Dermatol 155:1170–1176CrossRefPubMed
20.
go back to reference Hernández-Zendejas G, Guerrerosantos J (1998) Eyelash reconstruction and aesthetic augmentation with strip composite sideburn graft. Plast Reconstr Surg 101:1978–1980CrossRefPubMed Hernández-Zendejas G, Guerrerosantos J (1998) Eyelash reconstruction and aesthetic augmentation with strip composite sideburn graft. Plast Reconstr Surg 101:1978–1980CrossRefPubMed
21.
go back to reference Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, VanDenburgh AM, Chen K, Whitcup SM, for the Bimatoprost Study Groups 1, 2 (2002) One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol 120:1286–1293PubMed Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, VanDenburgh AM, Chen K, Whitcup SM, for the Bimatoprost Study Groups 1, 2 (2002) One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol 120:1286–1293PubMed
22.
go back to reference Smith S, Fagien S, Somogyi C, Whitcup SM, Beddingfield FC, Eyelash growth in subjects treated with bimatoprost ophthalmic solution 0.03%; a multicenter, randomized, double-masked, vehicle-controlled, parallel study. In: Poster presented at American Academy of Dermatology’s 67th Annual Meeting, San Francisco, CA, 6-9 Mar 2009, unpublished data Smith S, Fagien S, Somogyi C, Whitcup SM, Beddingfield FC, Eyelash growth in subjects treated with bimatoprost ophthalmic solution 0.03%; a multicenter, randomized, double-masked, vehicle-controlled, parallel study. In: Poster presented at American Academy of Dermatology’s 67th Annual Meeting, San Francisco, CA, 6-9 Mar 2009, unpublished data
23.
go back to reference Kapur R, Osmanovic S, Toyran S, Edward DP (2005) Bimatoprost-induced periocular skin hyperpigmentation: histopathological study. Arch Ophthalmol 123:1541–1546CrossRefPubMed Kapur R, Osmanovic S, Toyran S, Edward DP (2005) Bimatoprost-induced periocular skin hyperpigmentation: histopathological study. Arch Ophthalmol 123:1541–1546CrossRefPubMed
24.
go back to reference Williams RD, Cohen JS, Gross RL, Liu C-C, Safyan E, Batoosingh AL, for the Bimatoprost Study Group (2008) Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4. Br J Ophthalmol 92:1387–1392CrossRefPubMed Williams RD, Cohen JS, Gross RL, Liu C-C, Safyan E, Batoosingh AL, for the Bimatoprost Study Group (2008) Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4. Br J Ophthalmol 92:1387–1392CrossRefPubMed
25.
go back to reference Stjernschantz JW, Albert DM, Hu D-N, Drago F, Wistrand PJ (2002) Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol 47:162S–175SCrossRef Stjernschantz JW, Albert DM, Hu D-N, Drago F, Wistrand PJ (2002) Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol 47:162S–175SCrossRef
26.
go back to reference Brandt JD, VanDenburgh AM, Chen K, Whitcup SM, for the Bimatoprost Study Group (2001) Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial. Ophthalmology 108:1023–1031CrossRefPubMed Brandt JD, VanDenburgh AM, Chen K, Whitcup SM, for the Bimatoprost Study Group (2001) Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial. Ophthalmology 108:1023–1031CrossRefPubMed
27.
go back to reference Mansberger SL, Cioffi GA (2000) Eyelash formation secondary to latanoprost treatment in a patient with alopecia. Arch Ophthalmol 118:718–719PubMed Mansberger SL, Cioffi GA (2000) Eyelash formation secondary to latanoprost treatment in a patient with alopecia. Arch Ophthalmol 118:718–719PubMed
28.
go back to reference Eisenberg DL, Toris CB, Camras CB (2002) Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Surv Ophthalmol 47(suppl 1):S105–S115CrossRefPubMed Eisenberg DL, Toris CB, Camras CB (2002) Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Surv Ophthalmol 47(suppl 1):S105–S115CrossRefPubMed
29.
go back to reference Alm A, Grierson I, Shields MB (2008) Side effects associated with prostaglandin analog therapy. Surv Ophthalmol 53(suppl 1):S93–S105CrossRefPubMed Alm A, Grierson I, Shields MB (2008) Side effects associated with prostaglandin analog therapy. Surv Ophthalmol 53(suppl 1):S93–S105CrossRefPubMed
36.
go back to reference Choy I, Lin S (2008) Eyelash enhancement properties of topical dechloro ethylcloprostenolamide. J Cosmet Laser Ther 10:110–113CrossRefPubMed Choy I, Lin S (2008) Eyelash enhancement properties of topical dechloro ethylcloprostenolamide. J Cosmet Laser Ther 10:110–113CrossRefPubMed
Metadata
Title
Enhanced Eyelashes: Prescription and Over-the-Counter Options
Author
Derek Jones
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Aesthetic Plastic Surgery / Issue 1/2011
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-010-9561-3

Other articles of this Issue 1/2011

Aesthetic Plastic Surgery 1/2011 Go to the issue